Literature DB >> 26069157

Linear IgA/IgG bullous dermatosis reacts with multiple laminins and integrins.

Xiaoguang Li1, Atsunari Tsuchisaka1, Hua Qian1, Kwesi Teye1, Norito Ishii1, Ryosuke Sogame1, Kazutoshi Harada2, Daiki Nakagomi2, Shinji Shimada2, Chiharu Tateishi3, Yoshiaki Hirako4, Takashi Hashimoto1.   

Abstract

BACKGROUND: Since the original description by Zone et al in 1994, the disease entity and target antigens in linear IgA/IgG bullous dermatosis (LAGBD) have not been clarified in 20 years.
OBJECTIVES: To determine autoantibodies and autoantigens in a new LAGBD case which showed atypical clinical and histopathological findings without apparent mucosal involvement.
MATERIALS AND METHODS: We performed various indirect immunofluorescence and immunoblotting studies.
RESULTS: Indirect immunofluorescence of 1M NaCl-split skin showed IgG and IgA reactivity with both epidermal and dermal sides. Immunoblotting studies using various antigen sources revealed circulating IgG and IgA antibodies reactive with laminin-332, laminin-γ1 and integrin α6β4 in various patterns. Absorption study using recombinant proteins of laminin-γ1 indicated that the patient serum reacted with different epitopes between laminin-γ1 and laminin-γ2.
CONCLUSIONS: This study presented for the first time a LAGBD patient with IgG and IgA antibodies to various laminins and integrins.

Entities:  

Keywords:  integrin α6β4; laminin-332; laminin-γ1; linear IgA/IgG bullous dermatosis

Mesh:

Substances:

Year:  2015        PMID: 26069157     DOI: 10.1684/ejd.2015.2555

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  5 in total

1.  Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab.

Authors:  Dmitry Nedosekin; Kelsey Derrick Wilson; Katelynn Campbell; Sara Shalin; Henry K Wong
Journal:  JAAD Case Rep       Date:  2021-01-11

2.  Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine.

Authors:  William J Nahm; Michelle Juarez; Julie Wu; Randie H Kim
Journal:  J Cutan Pathol       Date:  2022-08-03       Impact factor: 1.458

Review 3.  Humoral Epitope Spreading in Autoimmune Bullous Diseases.

Authors:  Dario Didona; Giovanni Di Zenzo
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

Review 4.  Antigen recognition in the pathogenesis of immunoglobulin A-related autoimmune bullous diseases.

Authors:  Zhiliang Li; Ke Jing; Suo Li; Suying Feng
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

5.  Serum autoantibodies against the extracellular region of α6β4 integrin in a patient with dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid.

Authors:  Chigusa Yamashita; Noriko Arase; Shuhei Higuchi; Hisashi Arase; Junichi Takagi; Satoshi Nojima; Atsushi Tanemura; Manabu Fujimoto
Journal:  JAAD Case Rep       Date:  2021-12-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.